Auralis

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Auralis - overview

Location

Richmond, -, UK

Primary Industry

Pharmaceuticals

About

Auralis is based in the UK and develops a generic pharmaceutical products for niche markets.


Current Investors

Aquarius Equity Partners

Primary Industry

Pharmaceuticals

Sub Industries

Drug Stores/Convenience Stores, Pharmaceutical Research & Development, Medicinal Chemicals & Botanicals

Website

www.auralis.co.uk

Verticals

Manufacturing

Company Stage

Early Stage

Total Amount Raised

Subscriber access only

Auralis - financials

Fiscal Year EndedDec 31, 2010Dec 31, 2011Dec 31, 2012Dec 31, 2013Dec 31, 2014Dec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019Dec 31, 2020
Revenue (USD)2,130,0242,409,8622,548,8991,829,989960,000897,0001,278,0001,473,000---
% Revenue Growth (YoY)-13.1%5.8%(28.2%)(47.5%)(6.6%)42.5%15.3%---
EBITDA (USD)133,633266,558624,8161,148,711766,0001,493,0001,128,0001,473,000---
Operating Income (USD)(1,039,161)266,558624,8161,148,711766,0001,493,0001,128,0001,473,000---
Operating Margin(48.8%)11.1%24.5%62.8%79.8%166.4%88.3%100.0%---
% EBITDA Margin6.3%11.1%24.5%62.8%79.8%166.4%88.3%100.0%---
NET Income (USD)(982,412)261,665570,6491,151,274774,0001,504,0001,138,0001,251,000---
% Net Margin(46.1%)10.9%22.4%62.9%80.6%167.7%89.0%84.9%---
GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.